Neurology News

Patients who received enzyme-inducing antiseizure medications had increased risk for incident cardiovascular disease, according to results of a cohort study published in JAMA Neurology.

NIH Director Francis S. Collins, MD, PhD, who has served under three U.S. presidents, will step down from the position by the end of the year, according to an agency press release.

Researchers found no link between telestroke adoption and changes in stroke systems of care in a national sample of hospitals that implemented telestroke practices in EDs, according to a cross-sectional study published in JAMA Network Open.

Methylphenidate safely and effectively treated apathy in Alzheimer’s disease, according to results of a randomized placebo-controlled clinical trial published in JAMA Neurology.

The national blood inventory is at its lowest level for this time of the year since 2015, according to the Red Cross.

The cause of midlife migraines in women is likely multifactorial, though research suggests that fluctuating hormone levels may play a role, according to a speaker at the North American Menopause Society annual meeting.

Levetiracetam was well tolerated and appeared to improve performance on spatial memory and executive function tasks among patients with Alzheimer’s disease, according to results of a randomized clinical trial in JAMA Neurology.

Blood sugar levels at admission were significantly linked to risk for composite vascular events among patients with ischemic stroke and diabetes, according to results published in Neurology.

Work hard, play hard. Physicians, young and old, enjoy time off and vacationing.

PTC Therapeutics Inc. released results of a 5-year analysis that showed its novel gene therapy, PTC-AADC, improved outcomes among children with aromatic L-amino acid decarboxylase deficiency.